Ember LifeSciences Funding: $17M Raised, Series A (2025)
Ember LifeSciences is a Healthtech company based in Westlake Village, California. It has raised $17M in total funding. Latest round: Series A.
Ember LifeSciences funding overview
Ember LifeSciences is a Healthtech company based in Westlake Village, California. Ember LifeSciences has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for Ember LifeSciences runs through 2025; nothing later has been disclosed. Investors on record include Amgen Ventures, TDF Ventures, Sea Court Capital, Cardinal Health, Carrier Ventures, Mike Pompeo. 6 distinct backers are named across the disclosed rounds.
Ember LifeSciences has raised $17M in total disclosed funding across the rounds on record.
Who has invested in Ember LifeSciences?
Amgen Ventures, TDF Ventures, Sea Court Capital, Cardinal Health, Carrier Ventures, Mike Pompeo are named among the investors backing Ember LifeSciences.
What was the latest Ember LifeSciences funding round?
The most recent disclosed round is a Series A, announced in December 2025.
Where is Ember LifeSciences based?
Ember LifeSciences is based in Westlake Village, California.
What sector does Ember LifeSciences operate in?
Ember LifeSciences is tracked under Healthtech from Westlake Village, California, with $17M in disclosed funding.
When did Ember LifeSciences last raise?
The last disclosed Ember LifeSciences round closed in December 2025 at Series A.
Every Ember LifeSciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Healthtech companies in Westlake Village at a similar stage.
